Chinese General Practice ›› 2024, Vol. 27 ›› Issue (32): 3993-4000.DOI: 10.12114/j.issn.1007-9572.2023.0609
• Original Research • Previous Articles Next Articles
Received:
2023-09-26
Revised:
2024-01-05
Published:
2024-11-15
Online:
2024-08-08
Contact:
FU Rong
通讯作者:
付蓉
作者简介:
作者贡献:
刘娟、赵晶提出主要研究目标,负责研究的构思与设计,研究的实施,撰写论文;陈泽雯、李丹龄进行数据的收集与整理,统计学处理,图、表的绘制与展示;李昌进行论文的修订;付蓉负责文章的质量控制与审查,对文章整体负责,监督管理。
基金资助:
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0609
项目 | VM(n=22) | MD(n=23) | t(χ2)值 | P值 |
---|---|---|---|---|
性别[例(%)] | 7.032a | 0.008 | ||
男 | 4(18.2) | 13(56.5) | ||
女 | 18(81.8) | 10(43.5) | ||
年龄( | 48.8±12.6 | 49.5±16.4 | 0.171 | 0.865 |
家族史[例(%)] | ||||
头晕家族史 | 9(40.9) | 7(30.4) | 0.538a | 0.463 |
头痛家族史 | 10(45.5) | 1(4.3) | 10.288a | 0.001 |
头痛病史[例(%)] | 14(63.6) | 1(4.3) | 17.787a | <0.001 |
前庭症状分类[例(%)] | ||||
眩晕 | 2(9.1) | 2(8.7) | — | 1.000 |
头晕 | 3(13.6) | 6(26.1) | — | 0.459 |
前庭视觉症状 | 15(68.2) | 12(52.2) | 1.201a | 0.273 |
姿势症状 | 18(81.8) | 18(78.3) | — | 1.000 |
前庭症状病程( | 6.45±2.63 | 6.34±2.61 | 0.036 | 0.972 |
前庭症状程度[例(%)] | 0.658 | 0.732 | ||
轻度 | 0 | 0 | ||
中度 | 4(18.2) | 3(13.0) | ||
中-重度 | 4(18.2) | 3(13.0) | ||
重度 | 14(63.6) | 17(73.9) | ||
持续时间[例(%)] | 2.014 | 0.399 | ||
≤5 min | 0 | 0 | ||
>5~60 min | 3(13.6) | 6(26.1) | ||
>1~24 h | 16(72.7) | 12(52.2) | ||
>24~72 h | 3(13.6) | 5(21.7) | ||
>72 h | 0 | 0 | ||
伴随症状[例(%)] | ||||
恶心 | 18(81.8) | 18(78.3) | — | 1.000 |
呕吐 | 7(31.8) | 17(73.9) | 8.006a | 0.005 |
畏声 | 8(36.4) | 6(26.1) | 0.554a | 0.457 |
畏光 | 9(40.9) | 4(17.4) | 3.027a | 0.082 |
耳鸣 | 4(18.2) | 23(100.0) | 31.364a | <0.001 |
耳闷感 | 3(13.6) | 19(82.6) | 21.407a | <0.001 |
听力下降 | 3(13.6) | 23(100.0) | 34.379a | <0.001 |
头痛 | 17(77.3) | 2(8.7) | 21.677a | <0.001 |
Table 1 Comparison of demographic and clinical characteristics of VM and MD patients with HST positive
项目 | VM(n=22) | MD(n=23) | t(χ2)值 | P值 |
---|---|---|---|---|
性别[例(%)] | 7.032a | 0.008 | ||
男 | 4(18.2) | 13(56.5) | ||
女 | 18(81.8) | 10(43.5) | ||
年龄( | 48.8±12.6 | 49.5±16.4 | 0.171 | 0.865 |
家族史[例(%)] | ||||
头晕家族史 | 9(40.9) | 7(30.4) | 0.538a | 0.463 |
头痛家族史 | 10(45.5) | 1(4.3) | 10.288a | 0.001 |
头痛病史[例(%)] | 14(63.6) | 1(4.3) | 17.787a | <0.001 |
前庭症状分类[例(%)] | ||||
眩晕 | 2(9.1) | 2(8.7) | — | 1.000 |
头晕 | 3(13.6) | 6(26.1) | — | 0.459 |
前庭视觉症状 | 15(68.2) | 12(52.2) | 1.201a | 0.273 |
姿势症状 | 18(81.8) | 18(78.3) | — | 1.000 |
前庭症状病程( | 6.45±2.63 | 6.34±2.61 | 0.036 | 0.972 |
前庭症状程度[例(%)] | 0.658 | 0.732 | ||
轻度 | 0 | 0 | ||
中度 | 4(18.2) | 3(13.0) | ||
中-重度 | 4(18.2) | 3(13.0) | ||
重度 | 14(63.6) | 17(73.9) | ||
持续时间[例(%)] | 2.014 | 0.399 | ||
≤5 min | 0 | 0 | ||
>5~60 min | 3(13.6) | 6(26.1) | ||
>1~24 h | 16(72.7) | 12(52.2) | ||
>24~72 h | 3(13.6) | 5(21.7) | ||
>72 h | 0 | 0 | ||
伴随症状[例(%)] | ||||
恶心 | 18(81.8) | 18(78.3) | — | 1.000 |
呕吐 | 7(31.8) | 17(73.9) | 8.006a | 0.005 |
畏声 | 8(36.4) | 6(26.1) | 0.554a | 0.457 |
畏光 | 9(40.9) | 4(17.4) | 3.027a | 0.082 |
耳鸣 | 4(18.2) | 23(100.0) | 31.364a | <0.001 |
耳闷感 | 3(13.6) | 19(82.6) | 21.407a | <0.001 |
听力下降 | 3(13.6) | 23(100.0) | 34.379a | <0.001 |
头痛 | 17(77.3) | 2(8.7) | 21.677a | <0.001 |
分类 | 例数 | 纯音测听 | 温度试验 | ||
---|---|---|---|---|---|
正常 | 听力下降 | 正常 | 异常 | ||
VM | 22 | 19(86.4) | 3(13.6) | 13(59.1) | 9(40.9) |
MD | 23 | 0 | 23(100.0) | 11(47.8) | 12(52.2) |
χ2值 | 34.379 | 0.573 | |||
P值 | <0.001 | 0.449 |
Table 2 Comparison of vestibular cochlear results of VM and MD patients with HST positive
分类 | 例数 | 纯音测听 | 温度试验 | ||
---|---|---|---|---|---|
正常 | 听力下降 | 正常 | 异常 | ||
VM | 22 | 19(86.4) | 3(13.6) | 13(59.1) | 9(40.9) |
MD | 23 | 0 | 23(100.0) | 11(47.8) | 12(52.2) |
χ2值 | 34.379 | 0.573 | |||
P值 | <0.001 | 0.449 |
分类 | 例数 | VOR增益正常无扫视波 | VOR增益正常伴补偿性扫视波 | VOR增益下降伴补偿性扫视波 | VOR增益升高无扫视波 | VOR增益升高伴反向性扫视波 |
---|---|---|---|---|---|---|
VM | 22 | 18(81.8) | 1(4.5) | 2(9.1) | 1(4.5) | 0 |
MD | 23 | 11(47.8) | 2(8.7) | 10(43.5) | 0 | 0 |
χ2值 | 8.300 | |||||
P值 | 0.017 |
Table 3 Comparison of results of vHIT in VM and MD patients with HST positive
分类 | 例数 | VOR增益正常无扫视波 | VOR增益正常伴补偿性扫视波 | VOR增益下降伴补偿性扫视波 | VOR增益升高无扫视波 | VOR增益升高伴反向性扫视波 |
---|---|---|---|---|---|---|
VM | 22 | 18(81.8) | 1(4.5) | 2(9.1) | 1(4.5) | 0 |
MD | 23 | 11(47.8) | 2(8.7) | 10(43.5) | 0 | 0 |
χ2值 | 8.300 | |||||
P值 | 0.017 |
项目 | VM(n=22) | MD(n=23) | t(χ2)值 | P值 |
---|---|---|---|---|
HST | ||||
眼震类型[例(%)] | 34.379a | 0.109 | ||
水平眼震 | 19(86.4) | 23(100.0) | ||
垂直眼震 | 3(13.6) | 0 | ||
SPVmax( | 12.40±3.71 | 10.47±5.50 | 1.380 | 0.175 |
HSTST | ||||
眼震度数[例(%)] | ||||
眼震度数增加 | 2(9.1) | 0 | — | 0.233 |
眼震度数不变 | 3(13.6) | 0 | — | 0.109 |
眼震度数减小 | 17(77.3) | 23(100.0) | 19.158a | <0.001 |
TSI≥60% | 4(23.5) | 21(91.3) | ||
TSI<60% | 13(76.5) | 2(8.7) | ||
SPVmax( | 8.82±2.74 | 3.43±2.98 | 6.298 | <0.001 |
TSI( | 25.41±12.15 | 78.71±13.76 | 8.584 | <0.001 |
Table 4 Comparison of HST and HSTST between VM and MD patients wiht HST positive
项目 | VM(n=22) | MD(n=23) | t(χ2)值 | P值 |
---|---|---|---|---|
HST | ||||
眼震类型[例(%)] | 34.379a | 0.109 | ||
水平眼震 | 19(86.4) | 23(100.0) | ||
垂直眼震 | 3(13.6) | 0 | ||
SPVmax( | 12.40±3.71 | 10.47±5.50 | 1.380 | 0.175 |
HSTST | ||||
眼震度数[例(%)] | ||||
眼震度数增加 | 2(9.1) | 0 | — | 0.233 |
眼震度数不变 | 3(13.6) | 0 | — | 0.109 |
眼震度数减小 | 17(77.3) | 23(100.0) | 19.158a | <0.001 |
TSI≥60% | 4(23.5) | 21(91.3) | ||
TSI<60% | 13(76.5) | 2(8.7) | ||
SPVmax( | 8.82±2.74 | 3.43±2.98 | 6.298 | <0.001 |
TSI( | 25.41±12.15 | 78.71±13.76 | 8.584 | <0.001 |
[1] |
|
[2] |
|
[3] |
张小梅,郭伟,余东,等. 内耳磁共振钆造影与3D-FLAIR平扫对梅尼埃病患者前庭积水的诊断价值比较[J]. 成都医学院学报,2023,18(5):583-586. DOI:10.3969/j.issn.1674-2257.2023.05.009.
|
[4] |
|
[5] |
|
[6] |
|
[7] |
Headache Classification Committee of the International Headache Society(IHS) The International Classification of Headache Disorders,3rd edition[J]. Cephalalgia,2018,38(1):1-211. DOI:10.1177/0333102417738202.
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[1] | LI Hao, LI Peijin, LIU Tingting, CUI Yiyuan, LI Sicong, LIU Lixing, FENG Li, Working Group on Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment Guidelines for Cancer Pain. Guidelines on the Diagnosis and Treatment of Cancer Pain by Integrated Traditional Chinese and Western Medicine [J]. Chinese General Practice, 2025, 28(30): 3729-3740. |
[2] | ZHI Congcong, LI Xue, CHENG Yicheng, WANG Xiaolong, ZHENG Lihua. Guidelines for Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Hemorrhoids (2025 Edition) [J]. Chinese General Practice, 2025, 28(26): 3217-3228. |
[3] | PAN Qi, REN Jingjing, MA Fanghui, HU Mengjie. Survey of General Practitioners' Cognition and Needs for AI Assisted Diagnosis and Treatment Systems [J]. Chinese General Practice, 2025, 28(25): 3127-3136. |
[4] | Chinese Geriatrics Society, General Practice Branch of Zhejiang Medical Association, the Expert Collaboration Group on Medically Unspecified Disease in General Practice. Expert Consensus on the Diagnosis, Treatment, and Management of Emaciation (2025) [J]. Chinese General Practice, 2025, 28(21): 2577-2594. |
[5] | LIU Hongya, YU Dehua. Construction and Practice of Clinical Diagnosis and Treatment Technology Combining General Practice and Specialist in Shanghai Community [J]. Chinese General Practice, 2025, 28(19): 2390-2397. |
[6] | BIAN Ying, YIN Gang, ZHANG Zixun, TAO Hongbing. The Mechanism of Information Construction Enabling High-quality Development of Compact County-level Medical Consortium [J]. Chinese General Practice, 2025, 28(19): 2426-2432. |
[7] | DENG Yaqian, CAO Chunli, MA Jinmei, LI Wenxiao, XU Zelin, CHENG Jing, LI Jun. Predictive Value of S-Detect Combined with Virtual Touch Tissue Imaging Quantification in Axillary Lymph Node Metastasis of Breast Cancer [J]. Chinese General Practice, 2025, 28(17): 2149-2155. |
[8] | LI Jie, DU Yue, SHAO Shen, PAN Dong, ZHANG Yaxin. The Operational Efficiency of Traditional Chinese Medicine Diagnosis and Treatment Services in Primary Medical Institutions in Tianjin Based on DEA and SFA [J]. Chinese General Practice, 2025, 28(16): 1980-1986. |
[9] | GU Jie, HUANG Yanyan. Diagnosis and Comprehensive Management of Rare Diseases: the Indispensable Role of General Practitioners [J]. Chinese General Practice, 2025, 28(16): 1955-1960. |
[10] | Chinese Academy Society of Sleep Medicine, Chinese Medical Doctor Association, Sleep Medicine Group, China Neurologist Association. Chinese Guideline for Diagnosis and Treatment of Co-morbid Insomnia and Obstructive Sleep Apnea (2024) [J]. Chinese General Practice, 2025, 28(11): 1289-1303. |
[11] | HUANG Lujie, ZHANG Xiaoying, YU Shasha. Risk Factors, Prognosis and Rapid Screening in Patients with Acute Aortic Dissection Complicated with Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(09): 1100-1105. |
[12] | MA Xiaoxuan, WANG Rongqi. Research Progress in Metabolomics for HCC Diagnosis and Treatment [J]. Chinese General Practice, 2025, 28(08): 1017-1022. |
[13] | MA Hongyang, YUE Anna, SUN Kangyun. Familial Hypercholesterolemia: Diagnostic Differences between Domestic and Foreign Guidelines [J]. Chinese General Practice, 2025, 28(06): 655-665. |
[14] | DAI Yao, XUE Liping, ZHANG Shiqi, XU Min, ZHANG Qiu, HU Honglin. Congential Adrenal Hyperplasia Associated with CYP17A1 Gene Mutation: a Case Report and Literature Review [J]. Chinese General Practice, 2025, 28(06): 771-776. |
[15] | LI Lingqi, GAO Yinyan, ZHANG Yuqin, SUN Dingkui, WU Xinyin, ZHANG Weiru. Survey on the Status and Training Demands of Capabilities for Diagnosing and Treating Common Diseases of Primary Care General Practitioners in Hunan Province [J]. Chinese General Practice, 2025, 28(04): 443-449. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||